Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5283310
Max Phase: Preclinical
Molecular Formula: C31H41N5O10S
Molecular Weight: 675.76
Associated Items:
ID: ALA5283310
Max Phase: Preclinical
Molecular Formula: C31H41N5O10S
Molecular Weight: 675.76
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H](OCCCn2cc(CN([C@@H](C(=O)O)C(C)C)S(=O)(=O)c3ccc(-c4ccccc4)cc3)nn2)O[C@H](CO)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C31H41N5O10S/c1-19(2)27(30(41)42)36(47(43,44)24-12-10-22(11-13-24)21-8-5-4-6-9-21)17-23-16-35(34-33-23)14-7-15-45-31-26(32-20(3)38)29(40)28(39)25(18-37)46-31/h4-6,8-13,16,19,25-29,31,37,39-40H,7,14-15,17-18H2,1-3H3,(H,32,38)(H,41,42)/t25-,26-,27-,28-,29-,31-/m1/s1
Standard InChI Key: WLPRWJCCGMDGLQ-HATSJDEBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 675.76 | Molecular Weight (Monoisotopic): 675.2574 | AlogP: 0.60 | #Rotatable Bonds: 15 |
Polar Surface Area: 213.64 | Molecular Species: ACID | HBA: 12 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.22 | CX Basic pKa: 0.05 | CX LogP: 0.77 | CX LogD: -2.67 |
Aromatic Rings: 3 | Heavy Atoms: 47 | QED Weighted: 0.14 | Np Likeness Score: -0.27 |
1. Cuffaro D, Ciccone L, Rossello A, Nuti E, Santamaria S.. (2022) Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition., 65 (20.0): [PMID:36250680] [10.1021/acs.jmedchem.2c01177] |
Source(1):